BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 12437482)

  • 1. Single cell expression analysis--pharmacogenomic potential.
    Dixon AK; Lee K; Richardson PJ; Bell MI; Skynner MJ
    Pharmacogenomics; 2002 Nov; 3(6):809-22. PubMed ID: 12437482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenomic analysis: correlating molecular substructure classes with microarray gene expression data.
    Blower PE; Yang C; Fligner MA; Verducci JS; Yu L; Richman S; Weinstein JN
    Pharmacogenomics J; 2002; 2(4):259-71. PubMed ID: 12196914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression analysis as an aid to the identification of drug targets.
    Zanders ED
    Pharmacogenomics; 2000 Nov; 1(4):375-84. PubMed ID: 11257923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression databases--resources for pharmacogenomic R&D.
    Furness LM; Henrichwark S; Egerton M
    Pharmacogenomics; 2000 Aug; 1(3):281-8. PubMed ID: 11256579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene delivery with biocompatible cationic polymer: pharmacogenomic analysis on cell bioactivity.
    Masago K; Itaka K; Nishiyama N; Chung UI; Kataoka K
    Biomaterials; 2007 Dec; 28(34):5169-75. PubMed ID: 17664002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concise review: gene expression applied to toxicology.
    Farr S; Dunn RT
    Toxicol Sci; 1999 Jul; 50(1):1-9. PubMed ID: 10445747
    [No Abstract]   [Full Text] [Related]  

  • 7. Current pharmacogenomic approaches to clinical drug development.
    Murphy MP
    Pharmacogenomics; 2000 May; 1(2):115-23. PubMed ID: 11256585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional profiling of peripheral blood cells in clinical pharmacogenomic studies.
    Burczynski ME; Dorner AJ
    Pharmacogenomics; 2006 Mar; 7(2):187-202. PubMed ID: 16515398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of dietary phytophenols on the expression of microRNAs involved in mammalian cell homeostasis.
    Lançon A; Michaille JJ; Latruffe N
    J Sci Food Agric; 2013 Oct; 93(13):3155-64. PubMed ID: 23674481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methodological and statistical issues in pharmacogenomics.
    Peters BJ; Rodin AS; de Boer A; Maitland-van der Zee AH
    J Pharm Pharmacol; 2010 Feb; 62(2):161-6. PubMed ID: 20487194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane transporters and drug development: relevance to pharmacogenomics, nutrigenomics, epigenetics, and systems biology.
    Yan Q
    Methods Mol Biol; 2010; 637():1-21. PubMed ID: 20419427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oestrogen receptors and selective oestrogen receptor modulators: molecular and cellular pharmacology.
    Nilsson S; Koehler KF
    Basic Clin Pharmacol Toxicol; 2005 Jan; 96(1):15-25. PubMed ID: 15667591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management.
    Maruschke M; Reuter D; Koczan D; Hakenberg OW; Thiesen HJ
    BJU Int; 2011 Jul; 108(2 Pt 2):E29-35. PubMed ID: 21435154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of pharmacogenomics.
    Somogy A
    Proc West Pharmacol Soc; 2008; 51():1-4. PubMed ID: 19544663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relevance of alternative RNA splicing to pharmacogenomics.
    Bracco L; Kearsey J
    Trends Biotechnol; 2003 Aug; 21(8):346-53. PubMed ID: 12902171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenomic analysis of rhIL-11 treatment in the HLA-B27 rat model of inflammatory bowel disease.
    Peterson RL; Wang L; Albert L; Marchese E; Erickson J; Wong A; Mounts WM; Hayes L; Bouchard P; Keith J; Dorner AJ
    Pharmacogenomics J; 2002; 2(6):383-99. PubMed ID: 12629504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Connecting chemosensitivity, gene expression and disease.
    Covell DG
    Trends Pharmacol Sci; 2008 Jan; 29(1):1-5. PubMed ID: 18055024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A stochastic version of corticosteriod pharmacogenomic model.
    Qi X
    AAPS J; 2005 Jun; 7(1):E134-40. PubMed ID: 16146334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenomic predictor discovery in phase II clinical trials for breast cancer.
    Pusztai L; Anderson K; Hess KR
    Clin Cancer Res; 2007 Oct; 13(20):6080-6. PubMed ID: 17947471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Precise regulation of transgene expression level and control of cell physiology.
    Schucht R; Wirth D; May T
    Cell Biol Toxicol; 2010 Feb; 26(1):29-42. PubMed ID: 19763851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.